What is Prestige Consmr Healthcare Inc's earnings per share (EPS)?

Prestige Consmr Healthcare Inc (PBH) reported diluted earnings per share of $3.91 for fiscal year 2026. This represents a -8.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Prestige Consmr Healthcare Inc Financials

PBH

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows Prestige Consmr Healthcare Inc (PBH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PBH FY2025 2026-05-14

Prestige’s business engine is stable margin, high-cash conversion that turns roughly flat sales into faster deleveraging.

Across the loss year and the latest year, revenue stayed between $1.13B and $1.14B, yet reported earnings swung from a loss back to normal profitability. Because operating cash flow still sat near $230M and long-term debt later fell to $992.4M, the disturbance looks more like an accounting hit than a breakdown in the cash engine.

The company behaves like a cash-harvesting model: capital spending was only $8.2M against $251.5M of operating cash flow, so most cash generated was available after maintenance needs. In practice, cash generation is constrained more by working capital than by fixed-asset replacement.

Management has used that surplus to strengthen the balance sheet rather than chase expansion: long-term debt fell from $1.48B to $992.4M while revenue was mostly flat. The current ratio reaching 4.2x reinforces that short-term funding pressure has eased, so financing is leaning more on accumulated earnings than on debt.

Financial Health Signals

Financial Profile 66/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Prestige Consmr Healthcare Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Prestige Consmr Healthcare Inc has an operating margin of 28.4%, meaning the company retains $28 of operating profit per $100 of revenue. This strong profitability earns a score of 87/100, reflecting efficient cost management and pricing power. This is down from 29.6% the prior year.

Growth

Prestige Consmr Healthcare Inc's revenue declined 4.3% year-over-year, from $1.1B to $1.1B. This contraction results in a growth score of 31/100.

Leverage

Prestige Consmr Healthcare Inc carries a low D/E ratio of 0.53, meaning only $0.53 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.57, Prestige Consmr Healthcare Inc holds $3.57 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.

Cash Flow

Prestige Consmr Healthcare Inc converts 22.6% of revenue into free cash flow ($246.4M). This strong cash generation earns a score of 80/100.

Returns

Prestige Consmr Healthcare Inc's ROE of 10.1% shows moderate profitability relative to equity, earning a score of 36/100. This is down from 11.7% the prior year.

Altman Z-Score Grey Zone

2.24

Prestige Consmr Healthcare Inc scores 2.24, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

5/9

Prestige Consmr Healthcare Inc passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.35x

For every $1 of reported earnings, Prestige Consmr Healthcare Inc generates $1.35 in operating cash flow ($257.6M OCF vs $190.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

7.3x

Prestige Consmr Healthcare Inc earns $7.3 in operating income for every $1 of interest expense ($309.4M vs $42.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1B

YoY-4.3%

5Y CAGR+2.9%

10Y CAGR+3.0%

Prestige Consmr Healthcare Inc generated $1.1B in revenue in fiscal year 2026. This represents a decrease of 4.3% from the prior year.

EBITDA

$340.7M

YoY-7.2%

5Y CAGR+0.8%

10Y CAGR+1.8%

Prestige Consmr Healthcare Inc's EBITDA was $340.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.2% from the prior year.

Net Income

$190.3M

YoY-11.3%

5Y CAGR+2.9%

10Y CAGR+6.7%

Prestige Consmr Healthcare Inc reported $190.3M in net income in fiscal year 2026. This represents a decrease of 11.3% from the prior year.

EPS (Diluted)

$3.91

YoY-8.9%

5Y CAGR+3.8%

10Y CAGR+7.6%

Prestige Consmr Healthcare Inc earned $3.91 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 8.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$246.4M

YoY+1.3%

5Y CAGR+2.9%

10Y CAGR+3.6%

Prestige Consmr Healthcare Inc generated $246.4M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 1.3% from the prior year.

Cash & Debt

$63.9M

YoY-34.8%

5Y CAGR+14.6%

10Y CAGR+8.9%

Prestige Consmr Healthcare Inc held $63.9M in cash against $994.0M in long-term debt as of fiscal year 2026.

Dividends Per Share

N/A

Shares Outstanding

47M

YoY-4.1%

5Y CAGR-1.0%

10Y CAGR-1.1%

Prestige Consmr Healthcare Inc had 47M shares outstanding in fiscal year 2026. This represents a decrease of 4.1% from the prior year.

Margins & Returns

Gross Margin

54.7%

YoY-1.0pp

5Y CAGR-3.3pp

10Y CAGR-3.2pp

Prestige Consmr Healthcare Inc's gross margin was 54.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 1.0 percentage points from the prior year.

Operating Margin

28.4%

YoY-1.2pp

5Y CAGR-3.1pp

10Y CAGR-3.9pp

Prestige Consmr Healthcare Inc's operating margin was 28.4% in fiscal year 2026, reflecting core business profitability. This is down 1.2 percentage points from the prior year.

Net Margin

17.5%

YoY-1.4pp

5Y CAGR+0.0pp

10Y CAGR+5.1pp

Prestige Consmr Healthcare Inc's net profit margin was 17.5% in fiscal year 2026, showing the share of revenue converted to profit. This is down 1.4 percentage points from the prior year.

Return on Equity

10.1%

YoY-1.6pp

5Y CAGR-2.0pp

10Y CAGR-3.3pp

Prestige Consmr Healthcare Inc's ROE was 10.1% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 1.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$156.3M

YoY+203.4%

5Y CAGR+67.5%

Prestige Consmr Healthcare Inc spent $156.3M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 203.4% from the prior year.

Capital Expenditures

$11.2M

YoY+35.9%

5Y CAGR-12.9%

10Y CAGR+12.1%

Prestige Consmr Healthcare Inc invested $11.2M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 35.9% from the prior year.

PBH Income Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Revenue	$1.1B-4.3%	$1.1B+1.1%	$1.1B-0.2%	$1.1B+3.8%	$1.1B+15.2%	$943.4M
Cost of Revenue	$493.1M-2.0%	$503.3M+0.5%	$500.9M-0.3%	$502.4M+7.8%	$466.2M+17.8%	$395.9M
Gross Profit	$595.6M-6.1%	$634.5M+1.6%	$624.4M-0.1%	$625.3M+0.7%	$620.6M+13.4%	$547.5M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$116.4M+7.6%	$108.2M+1.9%	$106.2M-1.1%	$107.4M-0.1%	$107.5M+29.3%	$83.1M
Operating Income	$309.4M-8.1%	$336.8M-1.7%	$342.4M+1627.7%	-$22.4M-106.8%	$329.9M+10.9%	$297.4M
Interest Expense	-$42.3M-2452.2%	$1.8M-65.4%	$5.2M+18.2%	$4.4M-93.2%	$64.3M-21.9%	$82.3M
Income Tax	$67.2M-3.4%	$69.6M+4.3%	$66.7M+674.4%	-$11.6M-120.3%	$57.1M+44.8%	$39.4M
Net Income	$190.3M-11.3%	$214.6M+2.5%	$209.3M+354.3%	-$82.3M-140.1%	$205.4M+24.7%	$164.7M
EPS (Diluted)	$3.91-8.9%	$4.29+2.9%	$4.17+352.7%	$-1.65-140.8%	$4.04+24.3%	$3.25

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$281.6M-0.6%	$283.4M+3.4%	$274.1M+9.9%	$249.5M-15.8%	$296.5M+2.1%	$290.3M+2.3%	$283.8M+6.2%	$267.1M
Cost of Revenue	$135.3M+7.3%	$126.1M+2.9%	$122.5M+12.2%	$109.2M-13.7%	$126.5M-2.1%	$129.3M+2.3%	$126.4M+4.4%	$121.1M
Gross Profit	$146.3M-7.0%	$157.4M+3.8%	$151.6M+8.0%	$140.3M-17.5%	$170.0M+5.6%	$161.0M+2.3%	$157.4M+7.8%	$146.0M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$30.3M+2.0%	$29.7M+5.8%	$28.0M-1.5%	$28.5M+5.2%	$27.1M+3.3%	$26.2M+0.4%	$26.1M-9.8%	$28.9M
Operating Income	$75.5M-8.5%	$82.5M+3.5%	$79.7M+11.0%	$71.8M-18.9%	$88.4M-3.8%	$92.0M+9.0%	$84.3M+17.1%	$72.0M
Interest Expense	-$11.4M-7.1%	-$10.7M-6.3%	-$10.0M+1.6%	-$10.2M+70.9%	-$35.1M-406.2%	$11.5M-6.7%	$12.3M-6.5%	$13.1M
Income Tax	$10.8M-28.3%	$15.1M-43.8%	$26.9M+88.1%	$14.3M-39.9%	$23.8M+24.6%	$19.1M+10.6%	$17.3M+85.0%	$9.3M
Net Income	$53.9M+15.5%	$46.7M+10.6%	$42.2M-11.1%	$47.5M-5.3%	$50.1M-17.9%	$61.0M+12.2%	$54.4M+10.8%	$49.1M
EPS (Diluted)	N/A	$0.97+12.8%	$0.86-9.5%	$0.95	N/A	$1.22+11.9%	$1.09+11.2%	$0.98

PBH Balance Sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Total Assets	$3.5B+2.7%	$3.4B+2.5%	$3.3B-1.1%	$3.4B-8.6%	$3.7B+7.0%	$3.4B
Current Assets	$431.5M-3.8%	$448.3M+19.5%	$375.0M-4.3%	$391.7M+33.6%	$293.3M+8.7%	$269.8M
Cash & Equivalents	$63.9M-34.8%	$97.9M+110.6%	$46.5M-20.6%	$58.5M+115.2%	$27.2M-15.8%	$32.3M
Inventory	$159.1M+7.7%	$147.7M+6.5%	$138.7M-14.4%	$162.1M+34.7%	$120.3M+4.7%	$115.0M
Accounts Receivable	$191.9M-1.2%	$194.3M+9.9%	$176.8M+5.8%	$167.0M+19.9%	$139.3M+21.5%	$114.7M
Goodwill	$581.1M+10.2%	$527.4M-0.1%	$527.7M0.0%	$527.6M-8.9%	$579.0M+0.2%	$578.1M
Total Liabilities	$1.6B+2.5%	$1.6B-5.8%	$1.7B-12.8%	$1.9B-8.9%	$2.1B+1.1%	$2.1B
Current Liabilities	$120.9M+13.4%	$106.6M-8.9%	$117.0M-27.2%	$160.7M+12.1%	$143.4M+17.4%	$122.1M
Long-Term Debt	$994.0M+0.2%	$992.4M-12.6%	$1.1B-15.7%	$1.3B-8.9%	$1.5B-0.2%	$1.5B
Total Equity	$1.9B+2.9%	$1.8B+10.9%	$1.7B+14.4%	$1.4B-8.3%	$1.6B+16.1%	$1.4B
Retained Earnings	$1.7B+12.2%	$1.6B+16.0%	$1.3B+18.5%	$1.1B-6.8%	$1.2B+20.4%	$1.0B

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$3.5B0.0%	$3.5B+1.5%	$3.4B+0.3%	$3.4B+0.9%	$3.4B+2.2%	$3.3B+0.4%	$3.3B+0.3%	$3.3B
Current Assets	$431.5M-0.4%	$433.4M-12.9%	$497.4M+3.5%	$480.5M+7.2%	$448.3M+18.9%	$377.2M-0.9%	$380.7M+3.2%	$368.7M
Cash & Equivalents	$63.9M+2.4%	$62.4M-47.6%	$119.1M-14.6%	$139.5M+42.5%	$97.9M+92.4%	$50.9M-1.3%	$51.5M+50.5%	$34.3M
Inventory	$159.1M-2.7%	$163.6M+2.9%	$159.0M+3.8%	$153.1M+3.7%	$147.7M-2.5%	$151.5M-3.0%	$156.2M+2.8%	$152.0M
Accounts Receivable	$191.9M+0.8%	$190.5M-4.3%	$199.0M+18.2%	$168.4M-13.3%	$194.3M+16.2%	$167.3M+2.3%	$163.5M-4.7%	$171.7M
Goodwill	$581.1M0.0%	$581.2M+10.0%	$528.4M0.0%	$528.3M+0.2%	$527.4M0.0%	$527.2M-0.4%	$529.2M+0.1%	$528.4M
Total Liabilities	$1.6B-3.5%	$1.7B+3.0%	$1.6B+2.6%	$1.6B+0.6%	$1.6B+1.7%	$1.5B-2.8%	$1.6B-2.6%	$1.6B
Current Liabilities	$120.9M-13.4%	$139.6M+3.7%	$134.6M+22.7%	$109.7M+2.9%	$106.6M+4.0%	$102.5M-4.1%	$106.9M-6.3%	$114.1M
Long-Term Debt	$994.0M-3.8%	$1.0B+4.1%	$993.1M0.0%	$992.7M0.0%	$992.4M-0.8%	$1.0B-5.7%	$1.1B-3.6%	$1.1B
Total Equity	$1.9B+3.2%	$1.8B+0.2%	$1.8B-1.6%	$1.9B+1.1%	$1.8B+2.6%	$1.8B+3.3%	$1.7B+3.0%	$1.7B
Retained Earnings	$1.7B+3.2%	$1.7B+2.8%	$1.6B+2.6%	$1.6B+3.1%	$1.6B+3.3%	$1.5B+4.2%	$1.4B+3.9%	$1.4B

PBH Cash Flow Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	$257.6M+2.4%	$251.5M+1.0%	$248.9M+8.4%	$229.7M-11.6%	$259.9M+10.3%	$235.6M
Capital Expenditures	$11.2M+35.9%	$8.2M-13.9%	$9.6M+22.7%	$7.8M-19.3%	$9.6M-56.7%	$22.2M
Free Cash Flow	$246.4M+1.3%	$243.3M+1.6%	$239.4M+7.9%	$221.9M-11.3%	$250.3M+17.3%	$213.4M
Investing Cash Flow	-$136.8M-684.1%	-$17.5M+13.2%	-$20.1M-73.6%	-$11.6M+95.5%	-$256.5M-1053.2%	-$22.2M
Financing Cash Flow	-$156.1M+14.3%	-$182.1M+24.5%	-$241.0M-29.7%	-$185.8M-2355.4%	-$7.6M+97.3%	-$279.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$156.3M+203.4%	$51.5M+106.0%	$25.0M-50.0%	$50.0M	$0-100.0%	$11.9M

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	$42.8M-45.3%	$78.3M+36.2%	$57.5M-27.2%	$79.0M+27.8%	$61.8M-5.0%	$65.1M-6.7%	$69.8M+27.4%	$54.8M
Capital Expenditures	$5.2M+72.1%	$3.0M+44.1%	$2.1M+150.8%	$838K-75.9%	$3.5M+122.2%	$1.6M-22.7%	$2.0M+76.0%	$1.2M
Free Cash Flow	$37.6M-50.0%	$75.3M+35.9%	$55.4M-29.2%	$78.2M+33.9%	$58.4M-8.1%	$63.5M-6.3%	$67.8M+26.4%	$53.6M
Investing Cash Flow	-$3.4M+97.3%	-$128.6M-4289.2%	-$2.9M-51.1%	-$1.9M+44.3%	-$3.5M+64.6%	-$9.8M-384.3%	-$2.0M+4.8%	-$2.1M
Financing Cash Flow	-$38.1M-465.9%	-$6.7M+91.0%	-$74.9M-106.6%	-$36.3M-215.8%	-$11.5M+78.7%	-$53.9M-5.2%	-$51.2M+21.9%	-$65.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$690K-98.5%	$45.8M-38.9%	$75.0M+115.7%	$34.8M+207.4%	$11.3M+371.0%	$2.4M-79.7%	$11.8M-54.5%	$26.0M

PBH Financial Ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Gross Margin	54.7%-1.0pp	55.8%+0.3pp	55.5%+0.0pp	55.5%-1.7pp	57.1%-0.9pp	58.0%
Operating Margin	28.4%-1.2pp	29.6%-0.8pp	30.4%+32.4pp	-2.0%-32.4pp	30.4%-1.2pp	31.5%
Net Margin	17.5%-1.4pp	18.9%+0.3pp	18.6%+25.9pp	-7.3%-26.2pp	18.9%+1.4pp	17.5%
Return on Equity	10.1%-1.6pp	11.7%-0.9pp	12.7%+18.3pp	-5.7%-18.7pp	13.0%+0.9pp	12.1%
Return on Assets	5.5%-0.9pp	6.3%0.0pp	6.3%+8.8pp	-2.5%-8.1pp	5.6%+0.8pp	4.8%
Current Ratio	3.57-0.6	4.20+1.0	3.20+0.8	2.44+0.4	2.04-0.2	2.21
Debt-to-Equity	0.53-0.0	0.54-0.1	0.69-0.2	0.930.0	0.94-0.2	1.09
FCF Margin	22.6%+1.3pp	21.4%+0.1pp	21.3%+1.6pp	19.7%-3.4pp	23.0%+0.4pp	22.6%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	51.9%-3.6pp	55.5%+0.2pp	55.3%-0.9pp	56.2%-1.1pp	57.3%+1.9pp	55.5%0.0pp	55.5%+0.8pp	54.7%
Operating Margin	26.8%-2.3pp	29.1%+0.0pp	29.1%+0.3pp	28.8%-1.1pp	29.8%-1.9pp	31.7%+2.0pp	29.7%+2.8pp	27.0%
Net Margin	19.1%+2.7pp	16.5%+1.1pp	15.4%-3.6pp	19.0%+2.1pp	16.9%-4.1pp	21.0%+1.9pp	19.2%+0.8pp	18.4%
Return on Equity	2.9%+0.3pp	2.5%+0.2pp	2.3%-0.3pp	2.6%-0.2pp	2.7%-0.7pp	3.4%+0.3pp	3.1%+0.2pp	2.9%
Return on Assets	1.5%+0.2pp	1.3%+0.1pp	1.2%-0.1pp	1.4%-0.1pp	1.5%-0.4pp	1.8%+0.2pp	1.6%+0.2pp	1.5%
Current Ratio	3.57+0.5	3.11-0.6	3.70-0.7	4.38+0.2	4.20+0.5	3.68+0.1	3.56+0.3	3.23
Debt-to-Equity	0.53-0.0	0.56+0.0	0.540.0	0.540.0	0.54-0.0	0.56-0.1	0.61-0.0	0.65
FCF Margin	13.4%-13.2pp	26.6%+6.3pp	20.2%-11.1pp	31.3%+11.7pp	19.7%-2.2pp	21.9%-2.0pp	23.9%+3.8pp	20.1%

Similar Companies

Amneal Pharmaceuticals Inc AMRX

$3.9B

Perrigo Co Plc PRGO

$1.5B

Indivior Pharmaceuticals Inc. INDV

$4.4B

Hutchmed (China) Limited HCM

$2.0B

Lantheus Holding LNTH

$6.3B

Frequently Asked Questions

What is Prestige Consmr Healthcare Inc's annual revenue?

Prestige Consmr Healthcare Inc (PBH) reported $1.1B in total revenue for fiscal year 2026. This represents a -4.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Prestige Consmr Healthcare Inc's revenue growing?

Prestige Consmr Healthcare Inc (PBH) revenue declined by 4.3% year-over-year, from $1.1B to $1.1B in fiscal year 2026.

Is Prestige Consmr Healthcare Inc profitable?

Yes, Prestige Consmr Healthcare Inc (PBH) reported a net income of $190.3M in fiscal year 2026, with a net profit margin of 17.5%.

What is Prestige Consmr Healthcare Inc's EBITDA?

Prestige Consmr Healthcare Inc (PBH) had EBITDA of $340.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Prestige Consmr Healthcare Inc have?

As of fiscal year 2026, Prestige Consmr Healthcare Inc (PBH) had $63.9M in cash and equivalents against $994.0M in long-term debt.

What is Prestige Consmr Healthcare Inc's gross margin?

Prestige Consmr Healthcare Inc (PBH) had a gross margin of 54.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Prestige Consmr Healthcare Inc's operating margin?

Prestige Consmr Healthcare Inc (PBH) had an operating margin of 28.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Prestige Consmr Healthcare Inc's net profit margin?

Prestige Consmr Healthcare Inc (PBH) had a net profit margin of 17.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Prestige Consmr Healthcare Inc's return on equity (ROE)?

Prestige Consmr Healthcare Inc (PBH) has a return on equity of 10.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Prestige Consmr Healthcare Inc's free cash flow?

Prestige Consmr Healthcare Inc (PBH) generated $246.4M in free cash flow during fiscal year 2026. This represents a 1.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Prestige Consmr Healthcare Inc's operating cash flow?

Prestige Consmr Healthcare Inc (PBH) generated $257.6M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Prestige Consmr Healthcare Inc's total assets?

Prestige Consmr Healthcare Inc (PBH) had $3.5B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Prestige Consmr Healthcare Inc's capital expenditures?

Prestige Consmr Healthcare Inc (PBH) invested $11.2M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Does Prestige Consmr Healthcare Inc buy back shares?

Yes, Prestige Consmr Healthcare Inc (PBH) spent $156.3M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Prestige Consmr Healthcare Inc have outstanding?

Prestige Consmr Healthcare Inc (PBH) had 47M shares outstanding as of fiscal year 2026.

What is Prestige Consmr Healthcare Inc's current ratio?

Prestige Consmr Healthcare Inc (PBH) had a current ratio of 3.57 as of fiscal year 2026, which is generally considered healthy.

What is Prestige Consmr Healthcare Inc's debt-to-equity ratio?

Prestige Consmr Healthcare Inc (PBH) had a debt-to-equity ratio of 0.53 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Prestige Consmr Healthcare Inc's return on assets (ROA)?

Prestige Consmr Healthcare Inc (PBH) had a return on assets of 5.5% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Prestige Consmr Healthcare Inc's Altman Z-Score?

Prestige Consmr Healthcare Inc (PBH) has an Altman Z-Score of 2.24, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Prestige Consmr Healthcare Inc's Piotroski F-Score?

Prestige Consmr Healthcare Inc (PBH) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Prestige Consmr Healthcare Inc's earnings high quality?

Prestige Consmr Healthcare Inc (PBH) has an earnings quality ratio of 1.35x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Prestige Consmr Healthcare Inc cover its interest payments?

Prestige Consmr Healthcare Inc (PBH) has an interest coverage ratio of 7.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Prestige Consmr Healthcare Inc?

Prestige Consmr Healthcare Inc (PBH) scores 66 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.